The Role of Thromboxanes in Renal Disease

  • Aubrey R. Morrison
  • Julio E. Benabe
  • Alan Taylor


The thromboxanes constitute a family of carboxylic acids containing an oxane ring. They are formed from the prostaglandin endoperoxides enzymatically by the enzyme thromboxane synthetase. Thromboxane biosynthesis has been demonstrated in several biological tissues, e.g., platelets,1,2 lung,3 spleen,4 stomach,5 brain,6 and kidney.7–9 The biologically active species thromboxane A2 is a C-20 carboxylic acid containng an oxetane-oxane structure and is derived from the parent fatty acid 5,8,11,14-eicosatetraenoic acid (arachidonic acid). Thromboxane A2 is rapidly converted to thromboxane B2 by addition of H2O (t 1/2 in aqueous media at 37°, 30–40 sec). This shortlived compound owes its biological interest mainly to two characteristics: (1) In the platelet it is produced during aggregation, and inhibition of its production is associated with inhibition of aggregation and (2) it is a potent constrictor of smooth muscle (rabbit aorta-contracting substance) and its production has been implicated in the vasocontriction which mediates the reduction in blood flow associated with platelet vascular homeostasis.


Renal Blood Flow Unilateral Ureteral Obstruction Ureteral Obstruction Rabbit Kidney Prostaglandin Endoperoxide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hamberg M, Samuelsson B: Prostaglandin endoperoxides. Novel transformation of arachidonic acid in human platelets. Proc Nat Acad Sci USA 71: 3400–3404, 1974.PubMedCrossRefGoogle Scholar
  2. 2.
    Hamberg M, Svensson J, Samuelsson B: Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins. Proc Nat Acad Sci USA 71: 3824–3828, 1974.PubMedCrossRefGoogle Scholar
  3. 3.
    Hamberg M, Samuelsson B: Prostaglandin endoperoxides VII. Novel transformation of arachidonic acid in guinea pig lung. Biochem Biophys Res Commun 61: 942–949, 1974.PubMedCrossRefGoogle Scholar
  4. 4.
    Hamberg M: On the formation of thromboxane B2 and 12-L-Hydroxy 5,8,10,14-eicosatetraenoic acid (12ho-20:4) in tissue from guinea pig. Biochim Biophys Acta 431: 651–654, 1976.PubMedGoogle Scholar
  5. 5.
    Ali M, Zamecnitk J, Cerskus AL, et al: Synthesis of thromboxane B2 and prostaglandins by bovine gastic mucosal microsomes. Prostaglandins 14: 819–827, 1977.PubMedCrossRefGoogle Scholar
  6. 6.
    Wolfe LS, Rostworowski W, Marion J: Endogenous formation of the prostaglandin endoperoxide metabolite thromboxane B2 by brain tissue. Biochem Biophys Res Commun 70: 907–913, 1976.PubMedCrossRefGoogle Scholar
  7. 7.
    Morrison AR, Nishikawa K, Needleman P. Unmasking of thromboxane A2 synthesis by ureteral obstruction in the rabbit kidney. Nature 267: 259–260, 1977.PubMedCrossRefGoogle Scholar
  8. 8.
    Zenser TV, Herman CA, Gorman RR, et al: Metabolism and action of the prostaglandin endoperoxide PGH2 in rat kidney. Biochem Biophys Res Commun 79: 357–363, 1977.PubMedCrossRefGoogle Scholar
  9. 9.
    Morrison AR, Nishikawa K, Needleman P: Thromboxane A2 biosynthesis in the ureter obstructed isolated perfused kidney of the rabbit. J Pharmacol Exp Ther 205: 1–8, 1978.PubMedGoogle Scholar
  10. 10.
    Yarger WE, Griffith LD: Intrarenal hemodynamics foloowing chronic unilateral ureteral obstruction in the dog. Am J Physiol 227: 816–826, 1974.PubMedGoogle Scholar
  11. 11.
    Harris RH, Yarger WE: Renal function after release of unilateral ureteral obstruction in rats. Am J Physiol 227: 806–815, 1974.PubMedGoogle Scholar
  12. 12.
    Wilson DR: The influence of volume expansion on renal function after relief of chronic unilateral ureteral obstruction. Kidney Int 5: 402–410, 1974.PubMedCrossRefGoogle Scholar
  13. 13.
    Shenasky JH, Gillenwater JY, Graham SD, et al: Effects of vasoactive drugs on renal vascular resistance in obstructive disease. J Urol 106: 355–359, 1972.Google Scholar
  14. 14.
    Nishikawa K, Morrison A, Needleman P: Exaggerated prostaglandin biosynthesis and its influence on renal resistance in the isolated hydronephrotic rabbit kidney. J Clin Invest 59: 1143–1150, 1977.PubMedCrossRefGoogle Scholar
  15. 15.
    Reingold DF, Waters K, Holmberg S, et al: Differential biosynthesis of prostaglandins by hydronephrotic rabbit and cat kidneys. J Pharmacol Exp Ther 216: 510–515, 1981.PubMedGoogle Scholar
  16. 16.
    Morrison AR, Moritz H, Needleman P: Mechanism of enhanced renal prostaglanding biosynthesis in reter obstruction. Role of de novo protein synthesis. J Biol Chem 253: 8210–8212, 1978.PubMedGoogle Scholar
  17. 17.
    Morrison AR, Pascoe N, Needleman P: Perfusion-dependent induction of de novo synthesis of renal phosphatide acyl hydrolase in ureter obstructed rabbit kidney. J Biol Chem 255: 20–22, 1980.PubMedGoogle Scholar
  18. 18.
    Lowry OH, Rosebrough NJ, Farr AL, et al: Protein measurement with the Folin reagent. J Biol Chem 193: 265–275, 1951.PubMedGoogle Scholar
  19. 19.
    Morrison AR, Thornton F, Blumberg A, et al: Thromboxane A2 is the major arachidonic acid metabolite of human cortical hydronephrotic tissue. Prostaglandins 21: 471–481, 1981.PubMedCrossRefGoogle Scholar
  20. 20.
    Hassid A, Dunn MJ: Microsomal prostaglandin biosynthesis of human kidney. JBiol Chem 255: 2472–2475, 1980.Google Scholar
  21. 21.
    Miyamoto T, Taniguchi K, Tanonchi T, et al: Selective inhibitor of thromboxane synthetase. Pyridine and its derivatives. Advances in Prostaglandin and Thromboxane Research, Vol. 6, 443–445, 1980.PubMedGoogle Scholar
  22. 22.
    Kawasaki A, Needleman P: A selective thromboxane synthetase inhibitor that is effective in intact tissue. Fed Proc 40: 2468A, 1981.Google Scholar
  23. 23.
    Yarger WE, Schocken DD, Harris RH, et al: Obstructive nephropathy in the rat: Possible role for the renin-angiotensin system, prostaglandin, and thromboxanes in post obstructed renal function. J Clin Invest 65: 400–412, 1980.PubMedCrossRefGoogle Scholar
  24. 24.
    Haddy FJ, Sedt J, Fleishman M, et al: Effect of change in renal venous pressure upon renal vascular resistance urine and lymph flow rates. Am J Physiol 195: 97–110, 1958.Google Scholar
  25. 25.
    Yoshitoshi Y, Honda N, Morikawa A, et al: Alterations in renal hemodynamics induced by increased renal vein pressure in the rabbit kidney. Jpn Heart J 7: 289–299, 1966.PubMedCrossRefGoogle Scholar
  26. 26.
    Abe Y, Kishimoto K, Yomomato K, et al: Intrarenal distribution of blood flow during ureteral and venous pressure elevation. Am J Physiol 244: 746–757, 1973.Google Scholar
  27. 27.
    Zipser R, Myers S, Needleman P: Exaggerated prostaglandin and thromboxane synthesis in the rabbit with renal vein constriction. Circ Res 47: 231–237, 1980.PubMedGoogle Scholar
  28. 28.
    Nagle RB, Bulger RE, Cutler RE, et al: Unilateral obstructive nephropathy in the rabbit. I. Early morphologic, physiologic and histochemical changes. Lab Invest 28: 456–467, 1973.PubMedGoogle Scholar
  29. 29.
    Nagle RB, Kneiser MR, Bulger RE, et al: Induction of smooth muscle characteristics in renal interstitial fibroblasts during obstructive nephropathy. Lab Invest 29: 422–427, 1973.PubMedGoogle Scholar
  30. 30.
    Ayer G, Grandchamp A, Wyler T, et al: Intrarenal hemodynamics in glycerol induced myohemoglobinuric acute renal failure in the rat. Circ Res 29: 128–135, 1971.PubMedGoogle Scholar
  31. 31.
    Chedru MP, Baethke R, Oken DE: Renal cortical blood flow and glomerular filtration in myohemoglobinuric acute renal failure. Kidney Int 1: 232–239, 1972.PubMedCrossRefGoogle Scholar
  32. 32.
    Eliahou HE, Brodman RR, Friedman EA: Adrenergic blockers in ischaemic acute renal failure in the rat. Proc. Conf. on acute renal failure DHEW Publ No (NIH) 74–608 Washington, D.C., U.S. Govt. Printing Office 265–279, 1973.Google Scholar
  33. 33.
    Benabe JE, Klahr S, Hoffman MK, et al: Production of thromboxane A2 by the kidney in glycerol induced acute renal failure in the rabbit. Prostaglandins 19: 333–347, 1980.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1983

Authors and Affiliations

  • Aubrey R. Morrison
    • 1
  • Julio E. Benabe
    • 1
  • Alan Taylor
    • 1
  1. 1.Departments of Medicine and PharmacologyWashington University School of MedicineSt. LouisUSA

Personalised recommendations